

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIIB | NASDAQ | USD | Real-time | |
BIIB | Mexico | MXN | Delayed | |
BIIB | Frankfurt | EUR | Delayed | |
BIIB | Xetra | EUR | Delayed | |
BIIB | TradeGate | EUR | Delayed | |
BIIB | Santiago | USD | Delayed | |
BIIB | Buenos Aires | ARS | Delayed | |
BIIB34 | BM&FBovespa | BRL | Delayed | |
BIIB | Vienna | EUR | Delayed |
(Reuters) -Biogen Inc's treatment for a rare type of amyotrophic lateral sclerosis (ALS) was accepted for review by the U.S. health regulator, weeks after follow-up analyses of data from a failed...
By Manas Mishra (Reuters) -Biogen Inc on Wednesday tried to assuage investor worries by laying out a plan for its Alzheimer's disease drug being developed with Eisai Co (OTC:ESALY) Ltd and promising...
By Senad Karaahmetovic Shares of Biogen (NASDAQ:BIIB) are trading nearly unchanged in premarket despite the company beating Q2 estimates and raising full-year guidance. Biogen reported Q2 EPS of $5.25...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review